company background image
PRDA

Prodia Widyahusada IDX:PRDA Stock Report

Last Price

Rp6.55k

Market Cap

Rp6.1t

7D

2.7%

1Y

47.5%

Updated

19 May, 2022

Data

Company Financials +
PRDA fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance6/6
Financial Health6/6
Dividends4/6

PRDA Stock Overview

PT Prodia Widyahusada Tbk provides private clinical laboratory services.

Prodia Widyahusada Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Prodia Widyahusada
Historical stock prices
Current Share PriceRp6,550.00
52 Week HighRp10,000.00
52 Week LowRp4,000.00
Beta-0.074
1 Month Change-4.73%
3 Month Change-18.38%
1 Year Change47.52%
3 Year Change83.99%
5 Year Change62.53%
Change since IPO-0.76%

Recent News & Updates

Shareholder Returns

PRDAID HealthcareID Market
7D2.7%3.4%-1.0%
1Y47.5%16.8%18.2%

Return vs Industry: PRDA exceeded the ID Healthcare industry which returned 16.8% over the past year.

Return vs Market: PRDA exceeded the ID Market which returned 18.2% over the past year.

Price Volatility

Is PRDA's price volatile compared to industry and market?
PRDA volatility
PRDA Average Weekly Movement5.4%
Healthcare Industry Average Movement5.5%
Market Average Movement6.3%
10% most volatile stocks in ID Market12.2%
10% least volatile stocks in ID Market3.0%

Stable Share Price: PRDA is not significantly more volatile than the rest of ID stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: PRDA's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19732,915Dewi Muliatyhttps://www.prodia.co.id

PT Prodia Widyahusada Tbk provides private clinical laboratory services. The company offers laboratory, panel test, and other diagnostics support services. As of December 31, 2021, it operated 259 outlets comprising 10 Prodia Health Care and specialty clinic outlets, 142 clinical lab and medical labs, 98 point of care outlets, and 9 hospital collaboration labs in 34 provinces throughout Indonesia.

Prodia Widyahusada Fundamentals Summary

How do Prodia Widyahusada's earnings and revenue compare to its market cap?
PRDA fundamental statistics
Market CapRp6.14t
Earnings (TTM)Rp621.62b
Revenue (TTM)Rp2.65t

9.9x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PRDA income statement (TTM)
RevenueRp2.65t
Cost of RevenueRp1.02t
Gross ProfitRp1.63t
Other ExpensesRp1.01t
EarningsRp621.62b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)663.06
Gross Margin61.56%
Net Profit Margin23.44%
Debt/Equity Ratio0.3%

How did PRDA perform over the long term?

See historical performance and comparison

Dividends

6.1%

Current Dividend Yield

60%

Payout Ratio

Valuation

Is Prodia Widyahusada undervalued compared to its fair value and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: PRDA (IDR6550) is trading below our estimate of fair value (IDR14663.44)

Significantly Below Fair Value: PRDA is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: PRDA is good value based on its PE Ratio (9.9x) compared to the ID Healthcare industry average (19.9x).

PE vs Market: PRDA is good value based on its PE Ratio (9.9x) compared to the ID market (18.9x).


Price to Earnings Growth Ratio

PEG Ratio: PRDA is poor value based on its PEG Ratio (1.1x)


Price to Book Ratio

PB vs Industry: PRDA is overvalued based on its PB Ratio (2.7x) compared to the ID Healthcare industry average (1.9x).


Future Growth

How is Prodia Widyahusada forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


9.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: PRDA's forecast earnings growth (9% per year) is above the savings rate (7%).

Earnings vs Market: PRDA's earnings (9% per year) are forecast to grow slower than the ID market (11.1% per year).

High Growth Earnings: PRDA's earnings are forecast to grow, but not significantly.

Revenue vs Market: PRDA's revenue (6.4% per year) is forecast to grow slower than the ID market (11% per year).

High Growth Revenue: PRDA's revenue (6.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: PRDA's Return on Equity is forecast to be high in 3 years time (25.2%)


Past Performance

How has Prodia Widyahusada performed over the past 5 years?

Past Performance Score

6/6

Past Performance Score 6/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


36.3%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: PRDA has high quality earnings.

Growing Profit Margin: PRDA's current net profit margins (23.4%) are higher than last year (14.3%).


Past Earnings Growth Analysis

Earnings Trend: PRDA's earnings have grown significantly by 36.3% per year over the past 5 years.

Accelerating Growth: PRDA's earnings growth over the past year (131.3%) exceeds its 5-year average (36.3% per year).

Earnings vs Industry: PRDA earnings growth over the past year (131.3%) exceeded the Healthcare industry 121.6%.


Return on Equity

High ROE: PRDA's Return on Equity (27.6%) is considered high.


Financial Health

How is Prodia Widyahusada's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: PRDA's short term assets (IDR1,769.1B) exceed its short term liabilities (IDR268.9B).

Long Term Liabilities: PRDA's short term assets (IDR1,769.1B) exceed its long term liabilities (IDR197.4B).


Debt to Equity History and Analysis

Debt Level: PRDA has more cash than its total debt.

Reducing Debt: PRDA's debt to equity ratio has reduced from 7.6% to 0.3% over the past 5 years.

Debt Coverage: PRDA's debt is well covered by operating cash flow (13389.6%).

Interest Coverage: PRDA earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Prodia Widyahusada current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


6.07%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: PRDA's dividend (6.07%) is higher than the bottom 25% of dividend payers in the ID market (1.12%).

High Dividend: PRDA's dividend (6.07%) is in the top 25% of dividend payers in the ID market (4.1%)


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, PRDA has been paying a dividend for less than 10 years.

Growing Dividend: PRDA's dividend payments have increased, but the company has only paid a dividend for 5 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (60%), PRDA's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonable cash payout ratio (57.5%), PRDA's dividend payments are covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

1.3yrs

Average management tenure


CEO

Dewi Muliaty (60 yo)

13.08yrs

Tenure

Ms. Dewi Muliaty has been President Director of PT Prodia Widyahusada Tbk since April 16, 2009 and serves as its Director. Ms. Muliaty started her career in the Company since 1988 in Quality Control Sectio...


Leadership Team

Experienced Management: PRDA's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

Experienced Board: PRDA's board of directors are considered experienced (8.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

PT Prodia Widyahusada Tbk's employee growth, exchange listings and data sources


Key Information

  • Name: PT Prodia Widyahusada Tbk
  • Ticker: PRDA
  • Exchange: IDX
  • Founded: 1973
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: Rp6.141t
  • Shares outstanding: 937.50m
  • Website: https://www.prodia.co.id

Number of Employees


Location

  • PT Prodia Widyahusada Tbk
  • Prodia Tower
  • Jl. Kramat Raya No. 150
  • Jakarta Pusat
  • Jakarta Raya
  • 10430
  • Indonesia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/19 00:00
End of Day Share Price2022/05/19 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.